Behavioural Science Interventions to Improve Health EquityNCT06163222
Behavioural Interventions to Improve Equity in Outpatient Access
A study testing Additional message with behavioural science-informed content and associated web pages and Usual communication strategy in people with Behavioural Science Interventions to Improve Health Equity, run by Imperial College London at 1 site in United Kingdom.
Trial summary
The goal of this clinical trial is to improve health equity within outpatient service access. This is through design and behavioural science-informed interventions that aim to improve rates of first outpatient appointment attendance. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Behavioural Science Interventions to Improve Health Equity
- What is being tested?
- Additional message with behavioural science-informed content and associated web pages and Usual communication strategy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 13,389 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 8 Jan 2024to 20 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients who have been referred to their first outpatient appointment at one of five ICHT adult clinical specialties - Cardiology, Colorectal Surgery, Gastroenterology, Ophthalmology and Plastic Surgery.
Who cannot join
- Phone or video appointments
- Diagnostics appointments
- Two-week wait appointments
- Saturday or Sunday appointments
- Appointments without message reminders switched on in DrDoctor
- Patients who re-enter the study and receive >1 intervention
- Patients who received email message reminders about their appointment (until 23rd May 2024, after which they will be included due to change in ICHT communications approach)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Can User-centred Design and Behavioural-science Informed Interventions Improve Equity in Outpatient Access in North West London? A Non-randomised Controlled Trial
The goal of this clinical trial is to improve health equity within outpatient service access. This is through design and behavioural science-informed interventions that aim to improve rates of first outpatient appointment attendance. Health equity refers to the avoidable and unfair differences in health access, outcomes and experience between groups or populations. Outpatient services are those appointments where advice from a specialised medical professional is provided to a patient in a clinic setting.
This clinical trial aims to test different ways of supporting people to attend their first outpatient appointments at five clinical specialties (ophthalmology, gastroenterology, colorectal surgery, cardiology and plastic surgery) at Imperial College Healthcare NHS Trust (ICHT). It is specifically focused on improving attendance for people who are most likely to miss their appointment based on ICHT data, which includes people from minority ethnic backgrounds and people living in the most deprived postcodes.
Read more
The main question this clinical trial aims to answer is:
- Do behavioural science-informed message interventions improve rates of first outpatient appointment attendance in patients facing inequity of access based on ethnicity and deprivation?
The secondary questions this clinical trial aims to answer include:
- Do behavioural science-informed message interventions improve rates of first outpatient appointment attendance across all patient groups?
- Do behavioural science-informed message interventions increase the number of patients who "self-cancel" their appointment if they need to?
- In which patient groups did the message interventions have most impact, e.g., a certain age range?
- Which factors were associated with improved outpatient attendance rates specifically in participants from minority ethnic groups or living in area with highest level of deprivation?
- What was the overall outcome of all first outpatient appointments included in the clinical trial?
- What was the overall successful message delivery rate for the messages sent as part of the study? Were there particular participant groups that were more likely to have an undelivered message?
- What was the overall outcome of appointment attendance for people who received a text message intervention compared with receiving a text message and/or email intervention?
- How well did participants engage with the message interventions e.g. did they click the link provided in the message?
Read the detailed description
This clinical trial has been designed as a non-randomised controlled trial, aiming to test the impact of three design and behavioural science-informed interventions on first outpatient appointment attendance in groups at highest risk of inequity. The interventions will be tested in five clinical specialties at ICHT - cardiology, gastroenterology, ophthalmology, plastic surgery, and colorectal surgery. The study is estimated to last 48 weeks. The messages sent as part of the trial will be deployed by ICHT staff members who manage outpatient services.
Prior to conducting this trial, three message and web page interventions were co-designed with a diverse group of public members with good representation from the IMD and ethnicity groups facing inequity of access, ICHT staff, researchers, and behavioural science experts. These interventions were based on insights on barriers to appointment attendance gained from short qualitative interviews conducted with people who had missed appointments at ICHT and who also faced inequity based on ethnicity or deprivation.
This study has been designed to have four arms. These four arms will include a control arm, that will be the standard practice communication strategy used by each clinical specialty, as well as three intervention strategies. Currently the standard communications that patients receive before an outpatient appointment varies, but commonly patients receive a reminder 3 and 7 days before the appointment at ICHT. The three co-designed interventions for the trial are all based on an additional message reminder to this existing reminder schedule that will be sent to patients 14 days before their appointment. DrDoctor is the message provider that is currently used by ICHT and that the interventions will be housed in. The web pages will be housed in the existing ICHT website. All five clinical specialties will spend one week in each study arm, before cycling to the next arm. They will move from one arm to the next, until they return to their original study arm, resulting in continuous four-week cycles until the final study period is reached. Therefore, the five clinical specialties will all be in the same study arms at the same time and go through the cycle together until the sample size is reached. This method of allocation of clinics to study arms has been selected as it is not possible with the current technology being used at ICHT to randomise participants within clinics to different study arms.
Data will be collected on the message delivery and appointment outcomes throughout the trial and full analysis will take place at the end of the trial, once the sample size has been reached. The rate of missed appointments will be monitored throughout the study to assess if there is any backfire effect of the interventions.
For the first approximately 20 weeks of the study, only participants who received the intervention as a text message will be analysed. However after this point, as email notifications were turned on by ICHT for all patients, both text and/or email interventions will be analysed.
- Being tested
- Additional message with behavioural science-informed content and associated web pages, Usual communication strategy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Additional message with behavioural science-informed content and associated web pagesBehavioural
Behavioural science-informed messages sent 14-days prior to outpatient appointment which include links to re-designed web pages
Usual communication strategyOther
Usual communications sent from outpatient services to remind participants about their appointments
| Study group | Role | What they receive |
|---|---|---|
| Getting to your appointment | Experimental | Additional 14-day message reminder that includes link to new transport index web page Receives: Behavioral: Additional message with behavioural science-informed content and associated web pages |
| Help with travel costs | Experimental | Additional 14-day message reminder that includes link to new 'help with travel costs' web page Receives: Behavioral: Additional message with behavioural science-informed content and associated web pages |
| What to expect | Experimental | Additional 14-day message reminder that includes link to 'what to expect' web page Receives: Behavioral: Additional message with behavioural science-informed content and associated web pages |
| Usual communications | Active comparator | Existing communication strategy used for each of the five clinical specialties e.g. reminder messages 3 and 7 days prior to outpatient appointment Receives: Other: Usual communication strategy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Did Not Attend (DNA) rate for first outpatient appointment across five clinical specialties with an emphasis on participants' ethnicity and the deprivation level of their address (Index of Multiple Deprivation quintiles)
Did Not Attend (DNA) rate is the change over time in the number of people who do not attend their outpatient appointment without cancelling or rescheduling. This rate will be analysed for the clinics included in the study and to see if it changes over time with our interventions.
While this change in DNA rate over time will be analysed for all patients, the research team will focus particularly on how this changes with a patient's ethnicity and the deprivation of where they live. Deprivation is currently recorded by ICHT using the Index of Multiple Deprivation (IMD) which assigns a score to a patient's postcode to indicate its level of deprivation based on multiple factors.
Measured: End of study period (12 months)
Secondary outcomes (8)
Change in DNA rate at first outpatient appointment across all five clinical specialties for all participant groups
Did Not Attend (DNA) rate is the change over time in the number of people who do not attend their outpatient appointment without cancelling or rescheduling. This rate will be analysed for the clinics included in the study and to see if it changes over time with our interventions.
While the primary outcome focuses on ethnicity and deprivation, this outcome will focus on describing any other changes in DNA rate seen across all patient groups.
Measured: End of study period (12 months)
Change in Patient-Initiated Cancellation (PIC) rate for first outpatient appointment across all five clinical specialties.
Patient-Initiated Cancellation (PIC) rate is the change over time in the number of people who cancel their outpatient appointment ahead of time. This rate will be analysed for the clinics included in the study and to see if it changes over time with our interventions.
Measured: End of study period (12 months)
Change in DNA rate at first outpatient appointment across all five clinical specialties for population subgroups, controlling for variables such as ethnicity, participant demographics, clinic specialty and IMD
Did Not Attend (DNA) rate is the change over time in the number of people who do not attend their outpatient appointment without cancelling or rescheduling.
This will provide an evaluation of where the selected interventions had most impact according to patient characteristics. Focus will be given to analysing in more detail patients of 'Black', 'mixed' or 'other' ethnicity as well as those living in areas with the greatest level of deprivation (IMD quintile 1) to further understand what variables are associated with a decrease in DNA rates in these populations specifically.
Measured: End of study period (12 months)
Change in the rate of appointment outcomes (attended, DNA, PIC, Hospital-Initiated Cancellation) for first outpatient appointments across all five clinical specialties
Analysis will be carried out to understand what the outcomes of all appointments included in the study and how this changes from the start of the study. For example, the outcomes could be that the patient attended the appointment, missed the appointment, cancelled the appointment in advance or the hospital cancelled the appointment.
Measured: End of study period (12 months)
Differences between message delivery rate for study interventions across all five clinical specialties for different population subgroups
The study team will analyse the message delivery rate for the study interventions. This refers to the number of messages that were successfully delivered to study participants. This will be analysed to see if unsuccessful message delivery rates are associated with specific population subgroups e.g. patients living in more deprived areas.
Measured: End of study period (12 months)
Differences between each study intervention's click-through rate from message to web page for all participant groups
The click-through rate for the study interventions will be analysed as part of the study, which describes the proportion of people who click the link provided in the messages as part of the study to view the associated web page. The different interventions will be compared to see which had higher click-through rates over time.
Measured: End of study period (12 months)
Differences between each study intervention's web page engagement using Google Analytics for each of the study interventions for all participant groups
The Google Analytics report for the ICHT web pages developed as part of the study will be analysed to understand which parts of the pages that people engaged with most and how they interacted with the site, a tool and practice that is currently already used at ICHT. The different web pages reports will be compared with each other to review their engagement over time.
Measured: End of study period (12 months)
Change in the rate of appointment outcomes (attended, DNA, PIC, Hospital-Initiated Cancellation) for appointments that received text message-only and appointments that received text and/or email interventions
For the first approximately 20 weeks of the study, data will be analysed for appointments that received text message-only interventions. This is because only a small number of patients had opted into email reminders, so these patients were going to be removed for analysis. However, ICHT turned on automatic email notifications for all patients during the study, and after this stage both text message and email reminders will be analysed. The study team will analyse appointment attendance between people who received just the text message interventions compared with people who received text and email interventions, once ICHT had turned on email reminders.
Measured: End of study period (12 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Dec 2023
- Study start8 Jan 2024
- Primary completion20 Nov 2024
- Study completion20 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Behavioural Science Interventions to Improve Health EquityStudies of the same condition, open and under way.
- More trials run by Imperial College LondonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 13,389 participants (actual)
Sponsor and investigators
- Lead sponsor
- Imperial College London
- Sponsor type
- University, hospital or other
- Collaborators
- Imperial College Healthcare NHS Trust
- Responsible party
- Sponsor
- Investigators
- Sarah Huf, Principal investigator, Imperial College London
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06163222
- Sponsor's protocol ID
- 23IC8361
- Status last verified
- Apr 2025
- First submitted
- 21 Nov 2023
- Last updated
- 9 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No individual participant data will be shared with other researchers.
Publications
Huf S, Kerrison RS, King D, Chadborn T, Richmond A, Cunningham D, Friedman E, Shukla H, Tseng FM, Judah G, Darzi A, Vlaev I. Behavioral economics informed message content in text message reminders to improve cervical screening participation: Two pragmatic randomized controlled trials. Prev Med. 2020 Oct;139:106170. doi: 10.1016/j.ypmed.2020.106170. Epub 2020 Jun 29.
PubMed 32610059Acharya A, Ashrafian H, Cunningham D, Ruwende J, Darzi A, Judah G. Evaluating the impact of a novel behavioural science informed animation upon breast cancer screening uptake: protocol for a randomised controlled trial. BMC Public Health. 2022 Jul 19;22(1):1388. doi: 10.1186/s12889-022-13781-x.
PubMed 35854267Hallsworth M, Berry D, Sanders M, Sallis A, King D, Vlaev I, Darzi A. Stating Appointment Costs in SMS Reminders Reduces Missed Hospital Appointments: Findings from Two Randomised Controlled Trials. PLoS One. 2015 Sep 14;10(9):e0137306. doi: 10.1371/journal.pone.0137306. eCollection 2015.
PubMed 26366885
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can User-centred Design and Behavioural-science Informed Interventions Improve Equity in Outpatient Access in North West London? A Non-randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT06163222
- Acronym / sponsor ID
- 23IC8361
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 13,389 participants (actual)
- Lead sponsor
- Imperial College LondonUniversity, hospital or other
- Collaborators
- Imperial College Healthcare NHS Trust
- Study start
- 8 Jan 2024 (actual)
- Primary completion
- 20 Nov 2024 (actual)
- Study completion
- 20 Nov 2024 (actual)
- First posted
- 8 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to improve health equity within outpatient service access. This is through design and behavioural science-informed interventions that aim to improve rates of first outpatient appointment attendance. Health equity refers to the avoidable and unfair differences in health access, outcomes and experience between groups or populations. Outpatient services are those appointments where advice from a specialised medical professional is provided to a patient in a clinic setting.
This clinical trial aims to test different ways of supporting people to attend their first outpatient appointments at five clinical specialties (ophthalmology, gastroenterology, colorectal surgery, cardiology and plastic surgery) at Imperial College Healthcare NHS Trust (ICHT). It is specifically focused on improving attendance for people who are most likely to miss their appointment based on ICHT data, which includes people from minority ethnic backgrounds and people living in the most deprived postcodes.
The main question this clinical trial aims to answer is:
- Do behavioural science-informed message interventions improve rates of first outpatient appointment attendance in patients facing inequity of access based on ethnicity and deprivation?
The secondary questions this clinical trial aims to answer include:
- Do behavioural science-informed message interventions improve rates of first outpatient appointment attendance across all patient groups?
- Do behavioural science-informed message interventions increase the number of patients who "self-cancel" their appointment if they need to?
- In which patient groups did the message interventions have most impact, e.g., a certain age range?
- Which factors were associated with improved outpatient attendance rates specifically in participants from minority ethnic groups or living in area with highest level of deprivation?
- What was the overall outcome of all first outpatient appointments included in the clinical trial?
- What was the overall successful message delivery rate for the messages sent as part of the study? Were there particular participant groups that were more likely to have an undelivered message?
- What was the overall outcome of appointment attendance for people who received a text message intervention compared with receiving a text message and/or email intervention?
- How well did participants engage with the message interventions e.g. did they click the link provided in the message?
Detailed description
This clinical trial has been designed as a non-randomised controlled trial, aiming to test the impact of three design and behavioural science-informed interventions on first outpatient appointment attendance in groups at highest risk of inequity. The interventions will be tested in five clinical specialties at ICHT - cardiology, gastroenterology, ophthalmology, plastic surgery, and colorectal surgery. The study is estimated to last 48 weeks. The messages sent as part of the trial will be deployed by ICHT staff members who manage outpatient services.
Prior to conducting this trial, three message and web page interventions were co-designed with a diverse group of public members with good representation from the IMD and ethnicity groups facing inequity of access, ICHT staff, researchers, and behavioural science experts. These interventions were based on insights on barriers to appointment attendance gained from short qualitative interviews conducted with people who had missed appointments at ICHT and who also faced inequity based on ethnicity or deprivation.
This study has been designed to have four arms. These four arms will include a control arm, that will be the standard practice communication strategy used by each clinical specialty, as well as three intervention strategies. Currently the standard communications that patients receive before an outpatient appointment varies, but commonly patients receive a reminder 3 and 7 days before the appointment at ICHT. The three co-designed interventions for the trial are all based on an additional message reminder to this existing reminder schedule that will be sent to patients 14 days before their appointment. DrDoctor is the message provider that is currently used by ICHT and that the interventions will be housed in. The web pages will be housed in the existing ICHT website. All five clinical specialties will spend one week in each study arm, before cycling to the next arm. They will move from one arm to the next, until they return to their original study arm, resulting in continuous four-week cycles until the final study period is reached. Therefore, the five clinical specialties will all be in the same study arms at the same time and go through the cycle together until the sample size is reached. This method of allocation of clinics to study arms has been selected as it is not possible with the current technology being used at ICHT to randomise participants within clinics to different study arms.
Data will be collected on the message delivery and appointment outcomes throughout the trial and full analysis will take place at the end of the trial, once the sample size has been reached. The rate of missed appointments will be monitored throughout the study to assess if there is any backfire effect of the interventions.
For the first approximately 20 weeks of the study, only participants who received the intervention as a text message will be analysed. However after this point, as email notifications were turned on by ICHT for all patients, both text and/or email interventions will be analysed.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Getting to your appointment | Experimental | Behavioral: Additional message with behavioural science-informed content and associated web pagesAdditional 14-day message reminder that includes link to new transport index web page |
| Help with travel costs | Experimental | Behavioral: Additional message with behavioural science-informed content and associated web pagesAdditional 14-day message reminder that includes link to new 'help with travel costs' web page |
| What to expect | Experimental | Behavioral: Additional message with behavioural science-informed content and associated web pagesAdditional 14-day message reminder that includes link to 'what to expect' web page |
| Usual communications | Active comparator | Other: Usual communication strategyExisting communication strategy used for each of the five clinical specialties e.g. reminder messages 3 and 7 days prior to outpatient appointment |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All patients who have been referred to their first outpatient appointment at one of five ICHT adult clinical specialties - Cardiology, Colorectal Surgery, Gastroenterology, Ophthalmology and Plastic Surgery.
Key exclusion criteria (7 listed)
- Phone or video appointments
- Diagnostics appointments
- Two-week wait appointments
- Saturday or Sunday appointments
- Appointments without message reminders switched on in DrDoctor
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Additional message with behavioural science-informed content and associated web pagesBehavioural science-informed messages sent 14-days prior to outpatient appointment which include links to re-designed web pages | Behavioural | Getting to your appointment, Help with travel costs, What to expect |
| Usual communication strategyUsual communications sent from outpatient services to remind participants about their appointments | Other | Usual communications |
Primary outcome
Change in Did Not Attend (DNA) rate for first outpatient appointment across five clinical specialties with an emphasis on participants' ethnicity and the deprivation level of their address (Index of Multiple Deprivation quintiles)
Time frame: End of study period (12 months)
Did Not Attend (DNA) rate is the change over time in the number of people who do not attend their outpatient appointment without cancelling or rescheduling. This rate will be analysed for the clinics included in the study and to see if it changes over time with our interventions. While this change in DNA rate over time will be analysed for all patients, the research team will focus particularly on how this changes with a patient's ethnicity and the deprivation of where they live. Deprivation is currently recorded by ICHT using the Index of Multiple Deprivation (IMD) which assigns a score to a patient's postcode to indicate its level of deprivation based on multiple factors.
8 secondary outcomes
Change in DNA rate at first outpatient appointment across all five clinical specialties for all participant groups
Time frame: End of study period (12 months)
Change in Patient-Initiated Cancellation (PIC) rate for first outpatient appointment across all five clinical specialties.
Time frame: End of study period (12 months)
Change in DNA rate at first outpatient appointment across all five clinical specialties for population subgroups, controlling for variables such as ethnicity, participant demographics, clinic specialty and IMD
Time frame: End of study period (12 months)
Change in the rate of appointment outcomes (attended, DNA, PIC, Hospital-Initiated Cancellation) for first outpatient appointments across all five clinical specialties
Time frame: End of study period (12 months)
Differences between message delivery rate for study interventions across all five clinical specialties for different population subgroups
Time frame: End of study period (12 months)
Differences between each study intervention's click-through rate from message to web page for all participant groups
Time frame: End of study period (12 months)
Differences between each study intervention's web page engagement using Google Analytics for each of the study interventions for all participant groups
Time frame: End of study period (12 months)
Change in the rate of appointment outcomes (attended, DNA, PIC, Hospital-Initiated Cancellation) for appointments that received text message-only and appointments that received text and/or email interventions
Time frame: End of study period (12 months)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2025.
- Background: PubMed 32610059Huf S, Kerrison RS, King D, Chadborn T, Richmond A, Cunningham D, Friedman E, Shukla H, Tseng FM, Judah G, Darzi A, Vlaev I. Behavioral economics informed message content in text message reminders to improve cervical screening participation: Two pragmatic randomized controlled trials. Prev Med. 2020 Oct;139:106170. doi: 10.1016/j.ypmed.2020.106170. Epub 2020 Jun 29.
- Background: PubMed 35854267Acharya A, Ashrafian H, Cunningham D, Ruwende J, Darzi A, Judah G. Evaluating the impact of a novel behavioural science informed animation upon breast cancer screening uptake: protocol for a randomised controlled trial. BMC Public Health. 2022 Jul 19;22(1):1388. doi: 10.1186/s12889-022-13781-x.
- Background: PubMed 26366885Hallsworth M, Berry D, Sanders M, Sallis A, King D, Vlaev I, Darzi A. Stating Appointment Costs in SMS Reminders Reduces Missed Hospital Appointments: Findings from Two Randomised Controlled Trials. PLoS One. 2015 Sep 14;10(9):e0137306. doi: 10.1371/journal.pone.0137306. eCollection 2015.
- NHS England. Core20PLUS5 (adults) - an approach to reducing healthcare inequalities \[Internet\]. 2023 \[cited 2023 Nov 17\].Link provided by the sponsor.
- Individual participant dataSharing planned: No. No individual participant data will be shared with other researchers.
Related trials for Behavioural Science Interventions to Improve Health Equity
Not yet recruiting
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project
Obesity Prevention, Obesity and Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sarah Huf principal investigator
Imperial College London
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Additional message with behavioural science-informed content and associated web pages and Usual communication strategy in people with Behavioural Science Interventions to Improve Health Equity, run by Imperial College London at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Did Not Attend (DNA) rate for first outpatient appointment across five clinical specialties with an emphasis on participants' ethnicity and the deprivation level of their address (Index of Multiple Deprivation quintiles) (time frame: End of study period (12 months)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06163222, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2025.